The human heart contains four valves that help regulate the flow of blood through the heart chambers. The two atrioventricular valves, known as the mitral and tricuspid valves, allow blood to flow from the upper chambers (atria) into the lower chambers (ventricles) but prevent backflow when the ventricles contract. The two semilunar valves, called the aortic and pulmonary valves, allow blood to exit the heart into the main arteries but prevent backflow into the ventricles during ventricular relaxation between heartbeats. Sometimes, one or more of these valves becomes damaged or diseased and fails to function properly. This can cause serious complications if not addressed through medical intervention.

Types of Valve Disease
There are three main types of heart valve disease: stenosis, regurgitation, and atresia. Stenosis happens when one of the valves becomes narrowed and restricts blood flow. Regurgitation, also called insufficiency, occurs when a valve fails to close properly and allows blood to flow backwards. Atresia is a rare condition where a valve is absent from birth or fails to develop. Left untreated, valve disease can strain the heart and reduce its ability to pump blood efficiently, potentially leading to heart failure over time.

Surgical Options for Valve Repair and Replacement
In the past, valve disease was difficult to treat. But modern cardiovascular medicine now offers effective surgical approaches. For some patients with mild valve issues, the damaged leaflets can be repaired rather than replaced through valvuloplasty or valvotomy procedures. However, many individuals require a Prosthetic Heart Valve implant through open-heart surgery to correct severe valve abnormalities. There are two main types of artificial valves in use today: mechanical valves containing moving parts and tissue valves made from biological materials like pig or cow tissues.

Prosthetic Heart Valves: Mechanical Heart Valves
The first successful heart valve replacements used mechanical valves that replicated the function of natural valves through movable discs or leaflets. Some benefits of mechanical valves include longevity lasting up to 20-30 years with no structural deterioration. However, due to their non-biological nature, patients require lifelong anticoagulant medication therapy to prevent blood clots from forming on the valve surface. Additionally, the clicking sounds generated can sometimes cause a patient discomfort. Contemporary mechanical valves now come in various geometries and sizes to closely match native valve anatomy. Improved materials make them highly durable.

Prosthetic Heart Valve: Tissue Valves
As an alternative to mechanical valves, surgeons began implanting preserved natural tissue to recreate heart valve function. Porcine or bovine tissues treated with glutaraldehyde allow the valve to maintain suppleness while preventing degradation in the body. Besides avoiding blood thinners, tissue valves have a more natural opening and closing movement similar to native ones. But their biological material is prone to calcification and wear over 10-15 years on average. Younger recipients may need reoperation down the line as tissue valves have shorter lifespans compared to mechanical counterparts. Ongoing innovations look to address this limitation through novel fixation techniques and biomaterials.

Minimally Invasive Options
Over the past two decades, less invasive transcatheter approaches have emerged for high-risk patients deemed unsuitable for open-heart surgery. In transcatheter aortic valve replacement (TAVR), a replacement valve is compressed on a catheter and guided through an artery to the heart, where it is expanded into position to function like a surgical bioprosthesis. Early results found TAVR to be beneficial for inoperable elderly individuals. Younger demographics are now also candidates as the technology advances, promising less recovery time. Another method called transcatheter mitral valve repair targets the mitral position via catheter from the femoral or jugular vein, sparing a full sternotomy.

New Frontiers in Valve Innovation
Regenerative medicine research aims to engineer living, autologous heart valves customized for each patient. Tissue engineering combines scaffolds, patient-derived cells, and growth factors to form three-dimensional heart valve conduits. Innovations in decellularization help create stem cell-receptive biological backbones. Implant studies show recellularized grafts can grow and remodel in preclinical models. Clinical trials ongoing. Technology progress likewise yields miniaturized, stent-mounted valves for catheter delivery through smaller access routes from the arm or wrist. Robotic surgery brings enhanced visualization and tool control benefits to valve repairs and replacements.

Due to advances in medical and surgical management, most patients with heart valve disease today can expect effective treatment restoring cardiac function and significantly extending healthy life expectancy. Continued innovation promises less invasive, more durable valve therapies tailored for specific defects and disease etiologies. Regenerative solutions hold promise to one day reconstruct damaged valves from a patient's own cells and tissues. With further developments, more individuals worldwide may gain access to life-saving treatment. Heart valve disease will likely remain an important public health issue, highlighting the importance of ongoing research to improve diagnosis and management outcomes globally.

Get more insights on Prosthetic Heart Valves

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)